Legend Biotech (LEGN) Other Non-Current Assets (2020 - 2025)

Legend Biotech has reported Other Non-Current Assets for 6 years, with the latest figure at $12.4 million in Q4 2025.

• For the quarter ending Q4 2025, Other Non-Current Assets fell 4.62% year-over-year to $12.4 million; the trailing twelve-month figure through Dec 2025 stood at $12.4 million (down 4.62% YoY), and the FY2025 full-year result was $12.4 million, down 4.62% from the prior year.
• Other Non-Current Assets for Q4 2025 stood at $12.4 million, up from $11.0 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $24.6 million in Q1 2022, with the low at $3983.0 in Q1 2021.
• Historically, Other Non-Current Assets has averaged $5.2 million across 5 years, with a median of $1.8 million in 2024.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 618102.36% — and 2023, when it sank 95.69%.
• Legend Biotech's Other Non-Current Assets stood at $5.1 million in 2021, then plunged by 71.11% to $1.5 million in 2022, then rose by 0.4% to $1.5 million in 2023, then soared by 770.73% to $13.0 million in 2024, then retreated by 4.62% to $12.4 million in 2025.
• The last three Other Non-Current Assets figures came in at $12.4 million (Q4 2025), $11.0 million (Q3 2025), and $5.7 million (Q2 2025), per Business Quant data.